Nichi-Iko Pharmaceutical Co., Ltd.

Text Size

S
M
L

Japanese
English

COMPANYAbout Us

GENERICProduct Information

IRInvestor Relations

CORPORATE SOCIAL RESPONSIBILITYCSR

Nichi-Iko GroupIntegrated Report

INFORMATION

- 05/17/2022
  
  PRESS RELEASE
  
  Notice Regarding Change in Representative Board Member and Officer Appointments
- 05/17/2022
  
  PRESS RELEASE
  
  Notice of the Execution of Basic Agreement on Investment with Japan Industrial Solutions III Investment Limited
- 05/17/2022
  
  PRESS RELEASE
  
  Notice of Formal Application and Acceptance of Business Turnaround ADR
- 05/17/2022
  
  PRESS RELEASE
  
  Notice of Recording of Inventory Assets Appraisal Loss and Impairment Loss, Difference between Forecast of Full-Year Consolidated Results and Actual Results and Difference of Individual Financial Results Compared to Actual Results for the Previous Fiscal
- 03/09/2022
  
  PRESS RELEASE
  
  Consolidated Financial Result for the 3rd Quarter of the Fiscal Year Ending March,2022(IFRS)